Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer

被引：0
|
作者：
Tuerkmen, B.
Schmitt, M.
Schmalfeldt, B.
Trommler, P.
机构：
来源：
Electrophoresis | / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
    Lampelj, Maja
    Arko, Darja
    Cas-Sikosek, Nina
    Kavalar, Rajko
    Ravnik, Maja
    Jezersek-Novakovic, Barbara
    Dobnik, Sarah
    Dovnik, Nina Fokter
    Takac, Iztok
    RADIOLOGY AND ONCOLOGY, 2015, 49 (04) : 357 - 364
  • [22] Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysis
    Wolff, Claudia
    Malinowsky, Katharina
    Berg, Daniela
    Schragner, Kerstin
    Schuster, Tibor
    Walch, Axel
    Bronger, Holger
    Hoefler, Heinz
    Becker, Karl-Friedrich
    JOURNAL OF PATHOLOGY, 2011, 223 (01): : 54 - 63
  • [23] PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS
    BOUCHET, C
    SPYRATOS, F
    MARTIN, PM
    HACENE, K
    GENTILE, A
    OGLOBINE, J
    BRITISH JOURNAL OF CANCER, 1994, 69 (02) : 398 - 405
  • [24] PRONOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS
    BOUCHET, C
    SPYRATOS, F
    MARTIN, PM
    HACENE, K
    GENTILE, A
    OGLOBINE, J
    BULLETIN DU CANCER, 1994, 81 (09) : 770 - 779
  • [25] ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA∼PAI-1 and tPA∼PAI-1)
    Grebenschikov, N
    Sweep, F
    Geurts, A
    Andreasen, P
    De Witte, H
    Schousboe, S
    Heuvel, J
    Benraad, T
    INTERNATIONAL JOURNAL OF CANCER, 1999, 81 (04) : 598 - 606
  • [26] Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients
    de Witte, JH
    Sweep, CGJ
    Klijn, JGM
    Grebenschikov, N
    Peters, HA
    Look, MP
    van Tienoven, TH
    Heuvel, JJTM
    van Putten, WLJ
    Benraad, TJ
    Foekens, JA
    BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) : 1190 - 1198
  • [27] Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients
    J H de Witte
    C G J Sweep
    J G M Klijn
    N Grebenschikov
    H A Peters
    M P Look
    Th H van Tienoven
    J J T M Heuvel
    W L J van Putten
    Th J Benraad
    J A Foekens
    British Journal of Cancer, 1999, 79 : 1190 - 1198
  • [28] Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas
    Papadopoulou, S
    Scorilas, A
    Yotis, J
    Arnogianaki, N
    Plataniotis, G
    Agnanti, N
    Talieri, M
    TUMOR BIOLOGY, 2002, 23 (03) : 170 - 178
  • [29] PROGNOSTIC IMPACT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PAI-1 IN COMPLETELY RESECTED GASTRIC-CANCER
    NEKARDA, H
    SCHMITT, M
    ULM, K
    WENNINGER, A
    VOGELSANG, H
    BECKER, K
    RODER, JD
    FINK, U
    SIEWERT, JR
    CANCER RESEARCH, 1994, 54 (11) : 2900 - 2907
  • [30] The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-1) independently predicts response to first-line endocrine therapy in advanced breast cancer
    Manders, P
    Tjan-Heijnen, VCG
    Span, PN
    Grebenchtchikov, N
    Geurts-Moespot, AJ
    van Tienoven, DTH
    Beex, LAM
    Sweep, FCGJ
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (03) : 514 - 521
12345